Indoco Remedies Secures EU GMP Certification for Baddi Plant-III

Indoco Remedies Ltd. has received EU GMP certification for its Oral Solid Dosage (OSD) manufacturing facility, Plant-III, located in Baddi, Himachal Pradesh. The inspection was conducted by the German Health Authority (Berlin) from April 22, 2026, to April 27, 2026.

Reader Takeaway: EU GMP certification enhances export capabilities, but global regulatory compliance remains a continuous challenge.

What just happened

Indoco Remedies' Baddi Plant-III has successfully obtained EU Good Manufacturing Practice (GMP) certification. This means the facility meets the stringent quality and manufacturing standards required by European Union directives.

Why this matters

This certification is crucial for Indoco Remedies as it opens doors for exporting pharmaceutical products to regulated European markets. It validates the company's manufacturing quality and compliance with international standards, potentially boosting revenue and market reach.

The backstory

Indoco Remedies operates 10 manufacturing facilities, including 6 for Finished Dosage Forms (FDFs) and 4 for Active Pharmaceutical Ingredients (APIs). The company has an annual turnover of approximately US$175 million and employs over 6,000 people.

What changes now

With this certification, Indoco Remedies can now supply products manufactured at Plant-III to European countries, enhancing its global market presence and competitive positioning.

Risks to watch

While this is a positive development, ongoing adherence to evolving international regulatory standards and successful market penetration in Europe will be key.

Peer comparison

Many Indian pharmaceutical companies are actively seeking and obtaining EU GMP certifications to expand their global footprint. This certification places Indoco Remedies in a similar category of compliant exporters.

Context metrics (time-bound)

The inspection for this certification took place from April 22, 2026, to April 27, 2026.

What to track next

Investors will want to monitor the company's progress in securing new orders and launching products in European markets following this certification.